SCHEMBL7143531

SCHEMBL7143531

COCCOCCOCCOCCOc1cc(NC(=O)OC(C)(C)C)c([N+](=O)[O-])cc1C#Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 3/20 0.37
HPGD P15428 1/20 0.37
VCP P55072 1/20 0.37
SLC16A3 O15427 1/20 0.36
BCHE P06276 1/20 0.36
CNR2 P34972 1/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.36
MAPK1 P28482 2/20 0.36
HTT P42858 2/20 0.36
NPC1 O15118 1/20 0.36
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138020 0.97 ALDH1A1 (0.39) ALDH1A1KDM4EMAPTVCPKMT2A
SCHEMBL7138026 0.86 MAPT (0.41) ALDH1A1MAPTCYP3A4MAPK1HTT
SCHEMBL7142632 0.86 VCP (0.39) KDM4EHPGDVCPSLC16A3CNR2
SCHEMBL7146760 0.86 ALDH1A1 (0.39) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL7143195 0.85 FFAR1 (0.39) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL7141733 0.83 L3MBTL1 (0.40) ALDH1A1MAPTLMNAMAPK1HTT
SCHEMBL7142218 0.83 VCP (0.40) KDM4EHPGDVCPSLC16A3CNR2
SCHEMBL7139782 0.82 MEN1 (0.36) ALDH1A1KDM4EMAPTMEN1CYP2D6
SCHEMBL7141264 0.82 ADRA2A (0.38) ALDH1A1KDM4EMAPTCYP1A2CYP2C9
SCHEMBL7141773 0.81 ALDH1A1 (0.42) ALDH1A1KDM4EMAPTHPGDBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed